1-4 of 4
Jun Cai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Xiao-Peng Tian, Shu-Yun Ma, Ken H. Young, Choon Kiat Ong, Yanhui Liu, Zhihua Li, Qiongli Zhai, Hui-Qiang Huang, Tongyu Lin, Zhiming Li, Zhong-Jun Xia, Liye Zhong, Huilan Rao, Mei Li, Jun Cai, Yuchen Zhang, Fen Zhang, Ning Su, Peng-Fei Li, Feng Zhu, Zijun Yidan Xu-Monette, Esther Kam Yin Wong, Jeslin Chian Hung Ha, Lay Poh Khoo, Le Ai, Runfen Cheng, Jing Quan Lim, Sanjay de Mel, Siok-Bian Ng, Soon Thye Lim, Qingqing Cai
Journal: Blood
Blood blood.2020010637.
DOI: https://doi.org/10.1182/blood.2020010637
Published: 2021
Includes: Supplemental data
Journal Articles

Synergistic Antitumor Effect and Mechanism of Chidamide Combined with Gemcitabine, Oxaliplatin or Zanubrutinib in Diffuse Large B-Cell Lymphoma

Qingqing Cai, PhD, Tianying Huang, Master, Ning Su, MM, Xiaolu Xu, Master, Fengwei Wang, Doctor, Yu Fang, BMBS, Xiaopeng Tian, MDPhD, Jun Cai, BMBS, Shuyun Ma, MM, Yang Liang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
DOI: https://doi.org/10.1182/blood-2020-133487
Published: 2020
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-136842
Published: 2020
Journal Articles

Safety and Preliminary Efficacy of Sintilimab Plus P-Gemox (Pegaspargase, Gemcitabine and Oxaliplatin) Regimen As First-Line Treatment for Patients with Advanced Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: An Open-Label, Multicenter, Phase 2 Study

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Panpan Liu, MD PhD, Hui Zhou, MD PhD, Yajun Li, MD PhD, Yujing Zhang, MD PhD, Lixia Lu, MD PhD, Yan Gao, MD PhD, Xuanye Zhang, MDPhD, Yi Xia, MD PhD, Jun Cai, BMBS, Ning Su, MM, Shuyun Ma, MM, Hang Yang, MD PhD, Yu Fang, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
DOI: https://doi.org/10.1182/blood-2020-136949
Published: 2020